Heartflow
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 31 in the most recent period (2026/Q3).
- Total institutional ownership rose 6.9 percentage points.
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 113.01% +6.90pp
- Institutions
- 275 +31
- As of
- 2026/Q3 vs. prior period
Holder types
Top holders as of 2026-07-31
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 12 buys · 38 sells
| Name | Role | Stake |
|---|---|---|
| John Farquhar | Chief Executive Officer | 0.29% |
| William Weldon | Independent Chairperson | 0.28% |
| Timothy Barabe | Independent Director | 0.22% |
| Campbell Rogers | Chief Medical Officer & Executive VP | 0.18% |
| Vikram Verghese | Chief Financial Officer | 0.09% |
| Julie Cullivan | Independent Director | 0.03% |
| Casey Tansey | Independent Director | 0.02% |
| Mhairi Jones | -- | 0.01% |
| USVP Management Company, LLC | -- | -- |
| HealthCor Management L.P. | -- | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-09 | John Farquhar | Chief Executive Officer | Automatic Disposition | -23,280 | $55.74 |
| 2026-11-09 | John Farquhar | Chief Executive Officer | Derivative Exercise and Sale | -15,620 | $2.22–55.74 |
| 2026-11-08 | Vikram Verghese | Chief Financial Officer | Automatic Disposition | -3,587 | $53.15 |
| 2026-11-05 | Campbell Rogers | Chief Medical Officer & Executive VP | Sale to Issuer | -2,270 | $52.40 |
| 2026-11-05 | Mhairi Jones | -- | Sale to Issuer | -568 | $52.40 |
| 2026-11-05 | John Farquhar | Chief Executive Officer | Sale to Issuer | -7,751 | $52.40 |
| 2026-11-05 | Vikram Verghese | Chief Financial Officer | Sale to Issuer | -2,009 | $52.40 |
| 2026-10-21 | Campbell Rogers | Chief Medical Officer & Executive VP | Open Market Disposition | -6,503 | $55.01 |
| 2026-10-21 | Campbell Rogers | Chief Medical Officer & Executive VP | Derivative Exercise and Sale | -17,430 | $2.22–55.01 |
| 2026-10-11 | John Farquhar | Chief Executive Officer | Automatic Disposition | -38,900 | $49.57 |
| 2026-09-17 | Campbell Rogers | Chief Medical Officer & Executive VP | Automatic Disposition | -6,503 | $50.15 |
| 2026-09-17 | Campbell Rogers | Chief Medical Officer & Executive VP | Derivative Exercise and Sale | -13,179 | $2.22–50.15 |
| 2026-09-17 | Vikram Verghese | Chief Financial Officer | Automatic Disposition | -24,345 | $50.11–50.75 |
| 2026-09-17 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -16,766 | $50.75 |
| 2026-09-16 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -7,579 | $50.11 |
| 2026-09-14 | Vikram Verghese | Chief Financial Officer | Automatic Disposition | -34,975 | $50.01–50.24 |
| 2026-09-14 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -668 | $50.01 |
| 2026-09-13 | Vikram Verghese | Chief Financial Officer | Intent to Sell (Form 144) | -4,593 | $50.24 |
| 2026-09-10 | John Farquhar | Chief Executive Officer | Automatic Disposition | -38,900 | $46.42–50.00 |
| 2026-09-10 | John Farquhar | Chief Executive Officer | Intent to Sell (Form 144) | -3,890 | $50.00 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Heartflow discussion 0 comments